From the Editor

Apr 09, 2018
Pharmaceutical Executive
Pharma's evolving landscape in recent years has created the need to recruit experts from outside of industry—and establish new pathways for traditional executive roles in the life sciences.
Mar 07, 2018
Pharmaceutical Executive
Tackling some of the unintended consequences associated with value-based contracting in pharma and efforts to advance toward sustainable outcomes-based engagement.
Feb 06, 2018
Pharmaceutical Executive
Drawing parallels from the world of football coaching in evaluating and grooming future C-suite pharma leaders—call it the quest to see "what right looks like?"
Jan 09, 2018
Pharmaceutical Executive
The advent of immunocellular therapies marks a major milestone in medical innovation, but the path for these treatments in transforming patient care is still forming as they face challenges in clinical trials, pricing, and market acceptance.
Dec 13, 2017
Pharmaceutical Executive
FDA's approval of the first-ever digital medicine, while sparking legitimate concerns around ethics and trust, could signal improvements ahead to the much-chronicled woes in drug adherence and compliance.
Nov 01, 2017
Pharmaceutical Executive
Our annual look at the drug industry's pipeline—the progress and the setbacks—puts my thoughts on those people driving new science behind the scenes in pharmaceutical research.
Oct 01, 2017
Pharmaceutical Executive
As we again highlight a roster of emerging leaders in pharma, I wanted to recognize Pharm Exec's own unique team behind the scenes.
Sep 06, 2017
Pharmaceutical Executive
A big thank you to you, our readers, for lending your voice to Pharm Exec's editorial mission—giving you the information you need and want. Click ahead for a look at some of the future topics we'll be tackling.
Aug 07, 2017
Pharmaceutical Executive
As more states approve the use of medical marijuana—and its rising profile as potential opioid alternative—industry and FDA are stepping up their focus on developing cannabis-derived therapies.
Jul 07, 2017
Pharmaceutical Executive
As we step further into the waters of value-based contracting arrangements, lessons learned must be shared—including the role of the patient in the equation.
native1_300x100
lorem ipsum